Second South Korean deal to produce Russia's Sputnik V

SEOUL - South Korea's Huons Global Co Ltd will lead a consortium to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine per month, as Moscow seeks to increase production globally to meet rising demand.

The deal to produce Sputnik V - for export rather than domestic use - is the second in South Korea and comes after biotech firm GL Rapha signed a deal late last year to make more than 150 million doses of the vaccine per year. Shares in Huons Global jumped 29.8% to their daily limit on Friday, hitting their highest level since September 2018.